PUBLISHER: The Business Research Company | PRODUCT CODE: 1942496
PUBLISHER: The Business Research Company | PRODUCT CODE: 1942496
Breast tissue markers are small implanted devices used in breast cancer diagnosis and treatment to mark the location of a biopsy site, tumor, or suspicious area within the breast. They are typically placed during biopsy procedures to allow accurate identification of the site during future imaging, surgery, or treatment.
The main product types of breast tissue markers include metal and non-metal markers. Metal breast tissue markers are small metallic markers, commonly made of materials such as stainless steel, used to accurately locate and monitor breast tumors. The materials include non-biodegradable and partially biodegradable options, and the shapes include coil, ribbon, butterfly, V-shape, and others. These markers are used by end users such as hospitals, ambulatory surgical centers, diagnostic centers, and specialty clinics.
Tariffs are impacting the breast tissue markers market by increasing the cost of imported metals such as titanium, stainless steel, and gold, as well as specialized polymers used in non-metal markers. Segments like metal markers and polymer-based markers are most impacted, particularly in regions like Asia-Pacific and North America. While tariffs have raised production and supply costs, they have also encouraged domestic manufacturing, innovation in biodegradable markers, and the development of cost-efficient alternatives, strengthening local capabilities over time.
The breast tissue markers market research report is one of a series of new reports from The Business Research Company that provides breast tissue markers market statistics, including breast tissue markers industry global market size, regional shares, competitors with a breast tissue markers market share, detailed breast tissue markers market segments, market trends and opportunities, and any further data you may need to thrive in the breast tissue markers industry. This breast tissue markers market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The breast tissue markers market size has grown strongly in recent years. It will grow from $2.99 billion in 2025 to $3.24 billion in 2026 at a compound annual growth rate (CAGR) of 8.5%. The growth in the historic period can be attributed to limited availability of tissue marker materials, reliance on traditional metallic markers, growing breast cancer diagnosis rates, increasing hospital and surgical center adoption, demand for accurate biopsy site localization.
The breast tissue markers market size is expected to see strong growth in the next few years. It will grow to $4.43 billion in 2030 at a compound annual growth rate (CAGR) of 8.2%. The growth in the forecast period can be attributed to development of polymer-based and gelatin markers, expansion of minimally invasive biopsy procedures, rising investment in imaging-compatible tissue markers, increasing awareness of patient safety and marker biocompatibility, integration of tissue markers with advanced imaging systems. Major trends in the forecast period include increasing adoption of metal and non-metal tissue markers, rising preference for biodegradable and radiopaque markers, growth in breast cancer screening and biopsy procedures, demand for shape-specific markers for accurate localization, enhanced focus on imaging compatibility and patient safety.
The rise in the number of breast cancer cases is anticipated to support the expansion of the breast tissue markers market going forward. Breast cancer is a malignant tumor that originates in the cells of breast tissue. The increase in breast cancer cases is commonly associated with factors such as increased life expectancy, advancements in diagnostic methods, lifestyle changes, and environmental influences. Breast tissue markers are utilized in breast cancer care to assist in diagnosis, monitor disease progression, and guide treatment decisions by identifying specific proteins or genetic mutations. For example, in October 2025, according to Breastcancer.org, a US-based non-profit organization, it was reported that in 2025 an estimated 316,950 women are expected to be diagnosed with invasive breast cancer, along with approximately 59,080 new cases of non-invasive ductal carcinoma in situ (DCIS). Consequently, the rising number of breast cancer cases is strengthening the growth outlook of the breast tissue markers market.
Leading companies operating in the breast tissue markers market are focusing on developing innovative solutions, such as breast biopsy site markers, to enhance ultrasound visibility, improve ease of localization, and reduce displacement during surgical procedures. A breast biopsy site marker is a small implantable device placed at the biopsy site to mark the location for future imaging or surgical intervention. For example, in August 2023, Mammotome, a US-based provider of breast biopsy markers, introduced the HydroMARK Plus breast biopsy site marker. This marker incorporates a hydrogel design that expands upon contact with fluid, significantly enhancing ultrasound visibility. Its design supports accurate site marking and reliable localization for follow-up diagnostic and treatment procedures, while providing long-term stability within breast tissue and reducing the need for repeat interventions.
In July 2024, Hologic Inc., a US-based health technology company, acquired Endomagnetics Ltd. for an undisclosed amount. This acquisition enables Hologic to expand its breast cancer diagnostics and treatment portfolio by integrating Endomagnetics' advanced magnetic detection technologies. Endomagnetics Ltd. is a UK-based provider of breast tissue marker technologies.
Major companies operating in the breast tissue markers market are Johnson & Johnson Company, Medtronic PLC, Hologic Inc., Cook Medical Inc., Merit Medical Systems Inc., Argon Medical Devices Inc., Devicor Medical Products Inc., Endomag, Becton Dickinson and Company, INRAD Inc., Biopsy Sciences LLC, Carbon Medical Technologies Inc., Scion Medical Technologies LLC, SOMATEX Medical Technologies GmbH, Seno Medical Instruments Inc, Sterylab S.r.l., Biopsybell S.r.l., MDL S.r.l., SenoRx Inc, Elucent Medical, Cortex, Medax Medical Devices, Tsunami S.r.l., Ranfac Corp
North America was the largest region in the breast tissue markers market in 2025. The regions covered in the breast tissue markers market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the breast tissue markers market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The breast tissue markers consist of sales of radiofrequency identification (RFID) markers, magnetic markers, ultrasound-visible markers, and hydrogel markers. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Breast Tissue Markers Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses breast tissue markers market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for breast tissue markers ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The breast tissue markers market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.